Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $1.04 down -2.80%% from the previous closing price of $1.07. In other words, the price has decreased by -$2.80% from its previous closing price. On the day, 3.06 million shares were traded.
Ratios:
For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.81 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 17 ’25 when Looker Benjamin sold 6,422 shares for $1.15 per share. The transaction valued at 7,398 led to the insider holds 401,241 shares of the business.
Koenig Sheldon L. sold 30,474 shares of ESPR for $33,796 on Jun 17 ’25. The President and CEO now owns 1,541,488 shares after completing the transaction at $1.11 per share. On Jun 17 ’25, another insider, Halladay Benjamin, who serves as the Chief Financial Officer of the company, sold 7,229 shares for $1.15 each. As a result, the insider received 8,328 and left with 474,473 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is 7.50%, while the 200-Day Moving Average is calculated to be -40.48%.
Shares Statistics:
A total of 196.66M shares are outstanding, with a floating share count of 194.62M. Insiders hold about 1.80% of the company’s shares, while institutions hold 57.31% stake in the company.
